These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29162435)

  • 1. Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats.
    Bonato JM; Bassani TB; Milani H; Vital MABF; de Oliveira RMW
    Exp Neurol; 2018 Feb; 300():188-200. PubMed ID: 29162435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease.
    Santiago RM; Tonin FS; Barbiero J; Zaminelli T; Boschen SL; Andreatini R; Da Cunha C; Lima MM; Vital MA
    Neuroscience; 2015 Aug; 300():246-53. PubMed ID: 25999296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALCAR promote adult hippocampal neurogenesis by regulating cell-survival and cell death-related signals in rat model of Parkinson's disease like-phenotypes.
    Singh S; Mishra A; Mishra SK; Shukla S
    Neurochem Int; 2017 Sep; 108():388-396. PubMed ID: 28577987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.
    Laloux C; Petrault M; Lecointe C; Devos D; Bordet R
    Pharmacol Res; 2012 May; 65(5):514-22. PubMed ID: 22391246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt/β-catenin pathways in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Parul ; Shukla S
    Neurochem Int; 2019 Jan; 122():170-186. PubMed ID: 30500462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease.
    Chiu WH; Depboylu C; Hermanns G; Maurer L; Windolph A; Oertel WH; Ries V; Höglinger GU
    Neuropharmacology; 2015 Aug; 95():367-76. PubMed ID: 25839898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-801 (Dizocilpine) Regulates Multiple Steps of Adult Hippocampal Neurogenesis and Alters Psychological Symptoms via Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Srivastava N; Shukla S
    ACS Chem Neurosci; 2017 Mar; 8(3):592-605. PubMed ID: 27977132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson's disease.
    Machado MMF; Bassani TB; Cóppola-Segovia V; Moura ELR; Zanata SM; Andreatini R; Vital MABF
    Pharmacol Rep; 2019 Aug; 71(4):556-564. PubMed ID: 31132685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Shukla S
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes.
    Zhao Q; Wu X; Yan S; Xie X; Fan Y; Zhang J; Peng C; You Z
    J Neuroinflammation; 2016 Oct; 13(1):259. PubMed ID: 27716270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.
    Sadeghian M; Marinova-Mutafchieva L; Broom L; Davis JB; Virley D; Medhurst AD; Dexter DT
    J Neuroimmunol; 2012 May; 246(1-2):69-77. PubMed ID: 22498097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
    Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol improves nonmotor symptoms, attenuates neuroinflammation and favors hippocampal newborn neuronal maturation in a rat model of Parkinsonism.
    Mattos BA; Bonato JM; Splendor MC; Del Bel E; Milani H; Oliveira RMW
    Acta Neuropsychiatr; 2024 May; ():1-30. PubMed ID: 38770713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.
    Winter C; von Rumohr A; Mundt A; Petrus D; Klein J; Lee T; Morgenstern R; Kupsch A; Juckel G
    Behav Brain Res; 2007 Dec; 184(2):133-41. PubMed ID: 17698212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal hippocampal neurogenesis in Parkinson's disease: relevance to a new therapeutic target for depression with Parkinson's disease.
    Lim J; Bang Y; Choi HJ
    Arch Pharm Res; 2018 Oct; 41(10):943-954. PubMed ID: 30136247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine.
    Barbiero JK; Santiago RM; Persike DS; da Silva Fernandes MJ; Tonin FS; da Cunha C; Lucio Boschen S; Lima MM; Vital MA
    Behav Brain Res; 2014 Nov; 274():390-9. PubMed ID: 25127682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral pioglitazone ameliorates fructose-induced peripheral insulin resistance and hippocampal gliosis but not restores inhibited hippocampal adult neurogenesis.
    Liu WC; Wu CW; Tain YL; Fu MH; Hung CY; Chen IC; Chen LW; Wu KLH
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):274-285. PubMed ID: 29054390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
    Crotty S; Fitzgerald P; Tuohy E; Harris DM; Fisher A; Mandel A; Bolton AE; Sullivan AM; Nolan Y
    Eur J Neurosci; 2008 Jan; 27(2):294-300. PubMed ID: 18190522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.